Cardiovascular risk associated with ibrutinib use in chronic lymphocytic leukemia: a population-based cohort study
Abdel-Qadir H, Sabrie N, Leong D, Pang A, Austin PC, Prica A, Nanthakumar K, Calvillo-Argüelles O, Lee DS, Thavendiranathan P. J Clin Oncol. 2021; 39(31):3453-62. Epub 2021 Aug 31.